传奇生物不再并表后 金斯瑞预计2024年业绩大增

第一财经
17 Feb

从2019年到2023年,金斯瑞生物科技(01548.HK、下称“金斯瑞”)已连续亏损了五年,如今,业绩有望迎来反转。2月16日晚间,金斯瑞发布了正面盈利公告,公司预计2024年录得的净利润有重大增长。这背后,主要跟子公司传奇生物财务数据不再并入公司财务报表,而改为采用权益法进行会计处理有关。传奇生物2020年在美国纳斯达克上市时,曾与托管传奇生物美国存托股份的托管银行签订过一份协议,即传奇生物在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10